Gene	Study of Origin	Sample ID	Cancer Type	Cancer Type Detailed	Protein Change	Annotation	Custom Driver	Custom Driver Tiers	Functional Impact	Mutation Type	Variant Type	Copy #	MS	VS	Center	Chromosome	Start Pos	End Pos	Ref	Var	HGVSg	HGVSc	Allele Freq (T)	Allele Freq (N)	Variant Reads	Ref Reads	Variant Reads (Normal)	Ref Reads (Normal)	# Mut in Sample	Exon	gnomAD	ClinVar	dbSNP	SIGNAL	Diagnosis Age	Neoplasm Disease Stage American Joint Committee on Cancer Code	American Joint Committee on Cancer Publication Version Type	Aneuploidy Score	Buffa Hypoxia Score	TCGA PanCanAtlas Cancer Type Acronym	Last Communication Contact from Initial Pathologic Diagnosis Date	Birth from Initial Pathologic Diagnosis Date	Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value	Disease Free (Months)	Disease Free Status	Months of disease-specific survival	Disease-specific Survival status	Ethnicity Category	Form completion date	Fraction Genome Altered	Genetic Ancestry Label	Neoplasm Histologic Grade	Neoadjuvant Therapy Type Administered Prior To Resection Text	ICD-10 Classification	International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code	International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code	In PanCan Pathway Analysis	Informed consent verified	MSI MANTIS Score	MSIsensor Score	New Neoplasm Event Post Initial Therapy Indicator	Oncotree Code	Overall Survival (Months)	Overall Survival Status	Other Patient ID	American Joint Committee on Cancer Metastasis Stage Code	Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code	American Joint Committee on Cancer Tumor Stage Code	Person Neoplasm Cancer Status	Progress Free Survival (Months)	Progression Free Status	Primary Lymph Node Presentation Assessment	Prior Diagnosis	Race Category	Radiation Therapy	Ragnum Hypoxia Score	Number of Samples Per Patient	Sample Type	Sex	Somatic Status	Subtype	Tumor Break Load	Tissue Prospective Collection Indicator	Tissue Retrospective Collection Indicator	Tissue Source Site	Tissue Source Site Code	TMB (nonsynonymous)	Tumor Disease Anatomic Site	Tumor Type	Patient Weight	Winter Hypoxia Score
BRCA1	Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)	TCGA-20-1682-01	Ovarian Epithelial Tumor	Serous Ovarian Cancer	Y655Vfs*18	OncoKB: Likely Oncogenic, level_1, resistance NA;CIViC: NA;CancerHotspot: no;3DHotspot: no			MutationAssessor: NA;SIFT: NA;Polyphen-2: NA;AlphaMissense: NA	Frame_Shift_Ins	INS	ShallowDel	.	.	.	17	41245586	41245587	-	T	17:g.41245586_41245587insT	ENST00000357654.3:c.1961dup	0.54		95	82		256	88	10/23	0.0000119651	Pathogenic			56			10	23	OV	837	-20583	0	27.51750666	0:DiseaseFree	27.51750666	0:ALIVE OR DEAD TUMOR FREE	Not Hispanic Or Latino	6/2/09	0.8104	EUR	GX	No	C56.9	8441/3	C56.9	Yes	Yes	0.2609	1.58		SOC	27.51750666	0:LIVING	94bd4c68-4bfc-4db3-9365-97c867747133				Tumor Free	27.51750666	0:CENSORED			White	No	22	1	Primary	Female	Matched	OV	115			Fox Chase Cancer Center	20	2.9	Ovary	Serous Cystadenocarcinoma		18
BRCA1	Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)	TCGA-42-2591-01	Ovarian Epithelial Tumor	Serous Ovarian Cancer	M1?	OncoKB: Likely Oncogenic, level_1, resistance NA;CIViC: NA;CancerHotspot: no;3DHotspot: no			MutationAssessor: NA;SIFT: impact: deleterious, score: 0;Polyphen-2: impact: possibly_damaging, score: 0.878;AlphaMissense: NA	Translation_Start_Site	SNP	Diploid	.	.	.	17	41276113	41276113	T	C	17:g.41276113T>C	ENST00000357654.3:c.1A>G	0.93		148	11		201	63	2/23		Pathogenic/Likely_pathogenic	rs80357287		51			7		OV	1240	-18654	0	40.76667653	0:DiseaseFree	40.76667653	0:ALIVE OR DEAD TUMOR FREE	Not Hispanic Or Latino	6/3/10	0.9339	EUR	GX	No	C56.9	8441/3	C56.9	No	Yes	0.2927	1.98	No	SOC	40.76667653	0:LIVING	0750ebcc-348a-4ea9-9dd2-6274d5e6eeaa				Tumor Free	40.76667653	0:CENSORED			White	No		1	Primary	Female	Matched		213			Christiana Healthcare	42	2.1	Ovary	Serous Cystadenocarcinoma		
BRCA1	Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)	TCGA-24-1847-01	Ovarian Epithelial Tumor	Serous Ovarian Cancer	E111*	OncoKB: Likely Oncogenic, level_1, resistance NA;CIViC: NA;CancerHotspot: no;3DHotspot: no			MutationAssessor: NA;SIFT: NA;Polyphen-2: NA;AlphaMissense: NA	Nonsense_Mutation	SNP	ShallowDel	.	.	.	17	41256249	41256249	C	A	17:g.41256249C>A	ENST00000357654.3:c.331G>T	0.52		60	55		178	93	6/23		Pathogenic			45			13	23	OV	343	-16529	0			11.27658875	0:ALIVE OR DEAD TUMOR FREE		6/2/09	0.6355	EUR	G3	No	C56.9	8441/3	C56.9	Yes	Yes	0.2643	0.53		SOC	11.27658875	0:LIVING	21966708-4e66-4211-add0-f1515b09e362				Tumor Free	11.27658875	0:CENSORED			White	No	10	1	Primary	Female	Matched	OV	242			Washington University	24	3.1	Ovary	Serous Cystadenocarcinoma		22
BRCA1	Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)	TCGA-61-2096-01	Ovarian Epithelial Tumor	Serous Ovarian Cancer	W1837L	OncoKB: Likely Oncogenic, level_1, resistance NA;CIViC: NA;CancerHotspot: no;3DHotspot: no			MutationAssessor: NA;SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 1;AlphaMissense: pathogenicity: pathogenic, score: 0.9145	Missense_Mutation	SNP	ShallowDel	.	.	.	17	41197777	41197777	C	A	17:g.41197777C>A	ENST00000357654.3:c.5510G>T	0.78		49	14		120	116	23/23		not_provided	rs80357307		56			7		OV	1776	-20663	0			58.38840122	0:ALIVE OR DEAD TUMOR FREE		12/7/09	0.3766	EUR	G2	No	C56.9	8441/3	C56.9	No	Yes	0.2971	1.17		SOC	58.38840122	0:LIVING	6beaa1cb-a9f1-4127-898c-7aff2273788e				Tumor Free	13.84094421	1:PROGRESSION			White	No		1	Primary	Female	Matched		352			University of Pittsburgh	61	3.9	Ovary	Serous Cystadenocarcinoma		
BRCA1	Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)	TCGA-09-2043-01	Ovarian Epithelial Tumor	Serous Ovarian Cancer	W1718*	OncoKB: Likely Oncogenic, level_1, resistance NA;CIViC: NA;CancerHotspot: no;3DHotspot: no			MutationAssessor: NA;SIFT: NA;Polyphen-2: NA;AlphaMissense: NA	Nonsense_Mutation	SNP	Diploid	.	.	.	17	41215390	41215390	C	T	17:g.41215390C>T	ENST00000357654.3:c.5153G>A	0.80		77	19		103	105	18/23		Pathogenic	rs41293461		69			9		OV	188	-25480	0	6.180754184	0:DiseaseFree	6.180754184	0:ALIVE OR DEAD TUMOR FREE	Not Hispanic Or Latino	11/2/09	0.5683	EUR	G3	No	C56.9	8441/3	C56.9	No	Yes	0.3258	1.38		SOC	6.180754184	0:LIVING	2e05cd3a-a55f-43b8-b2a9-72fb742b89c9				Tumor Free	6.180754184	0:CENSORED			White	No		1	Primary	Female	Matched		337			UCSF	9	3.5	Ovary	Serous Cystadenocarcinoma		
BRCA1	Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)	TCGA-13-1489-01	Ovarian Epithelial Tumor	Serous Ovarian Cancer	N1265Kfs*4	OncoKB: Likely Oncogenic, level_1, resistance NA;CIViC: NA;CancerHotspot: no;3DHotspot: no			MutationAssessor: NA;SIFT: NA;Polyphen-2: NA;AlphaMissense: NA	Frame_Shift_Ins	INS	ShallowDel	.	.	.	17	41243753	41243754	-	TT	17:g.41243753_41243754insTT	ENST00000357654.3:c.3793_3794dup	0.55		251	203		604	58	10/23					70			19	37	OV	2521	-25768	0	26.49833974	1:Recurred/Progressed	83.93332676	0:ALIVE OR DEAD TUMOR FREE	Not Hispanic Or Latino	3/31/09	0.8985	EUR	G2	No	C56.9	8441/3	C56.9	Yes	Yes	0.3082	2.7	Yes	SOC	83.93332676	1:DECEASED	7248cd60-be22-44bc-bc58-f644db0940a2				With Tumor	26.49833974	1:PROGRESSION			White	No	12	1	Primary	Female	Matched	OV	186			Memorial Sloan Kettering	13	1.966666667	Ovary	Serous Cystadenocarcinoma		34
BRCA1	Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)	TCGA-04-1357-01	Ovarian Epithelial Tumor	Serous Ovarian Cancer	Q1538*	OncoKB: Likely Oncogenic, level_1, resistance NA;CIViC: NA;CancerHotspot: no;3DHotspot: no			MutationAssessor: NA;SIFT: NA;Polyphen-2: NA;AlphaMissense: NA	Nonsense_Mutation	SNP	Diploid	.	.	.	17	41226411	41226411	G	A	17:g.41226411G>A	ENST00000357654.3:c.4612C>T	0.61		415	270		598	86	14/23		Pathogenic	rs80356992		52			12	-13	OV		-18999	0				0:ALIVE OR DEAD TUMOR FREE		3/26/09	0.4413	EUR	G3	No	C56.9	8441/3	C56.9	Yes	Yes	0.2937	0.17		SOC		0:LIVING	feda41d8-ca56-425d-b149-4d5485328107						0:CENSORED				No	-12	1	Primary	Female	Matched	OV	106			Gynecologic Oncology Group	4	2.866666667	Ovary	Serous Cystadenocarcinoma		-34
BRCA1	Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)	TCGA-29-2427-01	Ovarian Epithelial Tumor	Serous Ovarian Cancer	L431*	OncoKB: Likely Oncogenic, level_1, resistance NA;CIViC: NA;CancerHotspot: no;3DHotspot: no			MutationAssessor: NA;SIFT: NA;Polyphen-2: NA;AlphaMissense: NA	Nonsense_Mutation	SNP	ShallowDel	.	.	.	17	41246256	41246256	A	C	17:g.41246256A>C	ENST00000357654.3:c.1292T>G	0.56		63	50		169	69	10/23		Pathogenic	rs80357346		60			10	5	OV	1900	-21940	0	52.01038893	1:Recurred/Progressed	62.46506888	0:ALIVE OR DEAD TUMOR FREE		2/8/10	0.3124	EUR	G3	No	C56.9	8441/3	C56.9	Yes	Yes	0.2676	0.2		SOC	62.46506888	0:LIVING	6f25001a-f890-4fd0-a994-e62a9ea5c6f3				With Tumor	52.01038893	1:PROGRESSION			White	No	6	1	Primary	Female	Matched	OV	41			Duke	29	2.3	Ovary	Serous Cystadenocarcinoma		-14
BRCA1	Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)	TCGA-36-2534-01	Ovarian Epithelial Tumor	Serous Ovarian Cancer	X1760_splice	OncoKB: Likely Oncogenic, level_1, resistance NA;CIViC: NA;CancerHotspot: no;3DHotspot: no			MutationAssessor: NA;SIFT: NA;Polyphen-2: NA;AlphaMissense: NA	Splice_Site	SNP	Diploid	.	.	.	17	41203135	41203135	C	A	17:g.41203135C>A	ENST00000357654.3:c.5278-1G>T	0.91		367	35		347	126		0.00000398175	Pathogenic	rs80358099		72			4		OV	907	-26621	0			29.8188513	0:ALIVE OR DEAD TUMOR FREE		8/18/10	0.4717	EUR	G3	No	C56.9	8441/3	C56.9	No	Yes	0.2821	1.71		SOC	29.8188513	0:LIVING	e08a619d-8a55-435d-8c41-a77a112ed889				With Tumor	12.59164283	1:PROGRESSION			White	No		1	Primary	Female	Matched		270			BC Cancer Agency	36	4.233333333	Ovary	Serous Cystadenocarcinoma		
BRCA1	Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)	TCGA-04-1335-01	Ovarian Epithelial Tumor	Serous Ovarian Cancer	I1108*	OncoKB: Likely Oncogenic, level_1, resistance NA;CIViC: NA;CancerHotspot: no;3DHotspot: no			MutationAssessor: NA;SIFT: NA;Polyphen-2: NA;AlphaMissense: NA	Frame_Shift_Del	DEL	ShallowDel	.	.	.	17	41244226	41244226	T	-	17:g.41244226del	ENST00000357654.3:c.3322del	0.33		39	81		82	15	10/23					60			6		OV	55	-21963	0			1.808199362	1:DEAD WITH TUMOR	Not Hispanic Or Latino	3/26/09	0.3906	AFR	G2	No	C56.9	8441/3	C56.9	No	Yes		14.65		SOC	1.808199362	1:DECEASED	ab3dbbbe-eed6-4a35-a505-1815225e86c9				With Tumor	1.808199362	1:PROGRESSION			Black or African American	No		1	Primary	Female	Matched		46			Gynecologic Oncology Group	4	0.5	Ovary	Serous Cystadenocarcinoma		
BRCA1	Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)	TCGA-23-2641-01	Ovarian Epithelial Tumor	Serous Ovarian Cancer	D749Vfs*4	OncoKB: Likely Oncogenic, level_1, resistance NA;CIViC: NA;CancerHotspot: no;3DHotspot: no			MutationAssessor: NA;SIFT: NA;Polyphen-2: NA;AlphaMissense: NA	Frame_Shift_Del	DEL	ShallowDel	.	.	.	17	41245302	41245302	T	-	17:g.41245302del	ENST00000357654.3:c.2246del	0.47		110	126		235	82	10/23					85			8		OV	84	-31232	0			2.761613571	0:ALIVE OR DEAD TUMOR FREE	Not Hispanic Or Latino	12/9/09	0.8725	EUR	G3	No	C56.9	8441/3	C56.9	No	Yes	0.3056	1.33		SOC	2.761613571	0:LIVING	49e5ee61-a1c9-4038-84ac-92683e573a65					2.761613571	0:CENSORED			White	No		1	Primary	Female	Matched		137			Cedars Sinai	23	2.733333333	Ovary	Serous Cystadenocarcinoma		
BRCA1	Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)	TCGA-24-1846-01	Ovarian Epithelial Tumor	Serous Ovarian Cancer	D1156Cfs*2	OncoKB: Likely Oncogenic, level_1, resistance NA;CIViC: NA;CancerHotspot: no;3DHotspot: no			MutationAssessor: NA;SIFT: NA;Polyphen-2: NA;AlphaMissense: NA	Nonsense_Mutation	INS	ShallowDel	.	.	.	17	41244082	41244083	-	ATCTAACA	17:g.41244082_41244083insATCTAACA	ENST00000357654.3:c.3458_3465dup	0.55		95	79		264	105	10/23					45			10	-1	OV	133	-16534	0			4.372554821	0:ALIVE OR DEAD TUMOR FREE		6/2/09	0.9838	EUR	G3	No	C56.9	8441/3	C56.9	Yes	Yes	0.2941	2.34		SOC	4.372554821	0:LIVING	67f526f1-def5-43b4-bc89-154baae190fc					4.372554821	0:CENSORED				No	4	1	Primary	Female	Matched	OV	89			Washington University	24	3.566666667	Ovary	Serous Cystadenocarcinoma		0
BRCA1	Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)	TCGA-29-1768-01	Ovarian Epithelial Tumor	Serous Ovarian Cancer	D295Tfs*3	OncoKB: Likely Oncogenic, level_1, resistance NA;CIViC: NA;CancerHotspot: no;3DHotspot: no			MutationAssessor: NA;SIFT: NA;Polyphen-2: NA;AlphaMissense: NA	Frame_Shift_Del	DEL	Diploid	.	.	.	17	41246666	41246666	T	-	17:g.41246666del	ENST00000357654.3:c.882del	0.25		55	164		87	46	10/23		Pathogenic			50			7		OV	950	-18396	0			31.29828714	1:DEAD WITH TUMOR		6/2/09	0.3906	EUR	G3	No	C56.9	8441/3	C56.9	No	Yes	0.3402	0.03		SOC	31.29828714	1:DECEASED	838693d5-1ae0-4d75-834b-e1b89b96b0ed				With Tumor	17.98336457	1:PROGRESSION			White	No		1	Primary	Female	Matched		92			Duke	29	1.533333333	Ovary	Serous Cystadenocarcinoma		
BRCA1	Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)	TCGA-29-1776-01	Ovarian Epithelial Tumor	Serous Ovarian Cancer	R1188Efs*3	OncoKB: Likely Oncogenic, level_1, resistance NA;CIViC: NA;CancerHotspot: no;3DHotspot: no			MutationAssessor: NA;SIFT: NA;Polyphen-2: NA;AlphaMissense: NA	Frame_Shift_Del	DEL	ShallowDel	.	.	.	17	41243985	41243986	CT	-	17:g.41243985_41243986del	ENST00000357654.3:c.3562_3563del	0.50		91	91		143	55	10/23					63			7	-7	OV	360	-23016	0			11.83548673	0:ALIVE OR DEAD TUMOR FREE		6/2/09	0.4367	AFR	G3	No	C56.9	8441/3	C56.9	Yes	Yes	0.2815	1.6		SOC	11.83548673	0:LIVING	7472b3ba-9b15-4d97-8708-a2dd82ca0f45				With Tumor	11.83548673	0:CENSORED			Black or African American	No	-10	1	Primary	Female	Matched	OV	73			Duke	29	1.833333333	Ovary	Serous Cystadenocarcinoma		-2
BRCA1	Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)	TCGA-30-1857-01	Ovarian Epithelial Tumor	Serous Ovarian Cancer	K800*	OncoKB: Likely Oncogenic, level_1, resistance NA;CIViC: NA;CancerHotspot: no;3DHotspot: no			MutationAssessor: NA;SIFT: NA;Polyphen-2: NA;AlphaMissense: NA	Nonsense_Mutation	SNP	ShallowDel	.	.	.	17	41245150	41245150	T	A	17:g.41245150T>A	ENST00000357654.3:c.2398A>T	0.58		166	118		288	103	10/23			rs2154379697		64			8	13	OV	8	-23689	0			0.263010816	1:DEAD WITH TUMOR	Not Hispanic Or Latino	6/2/09	0.4428	EUR	G3	No	C56.9	8441/3	C56.9	No	Yes	0.271	0.3		SOC	0.263010816	1:DECEASED	45baebac-32ae-4093-9eba-488b95c1a58d				With Tumor	0.263010816	1:PROGRESSION			White	No	0	1	Primary	Female	Matched		200			Harvard	30	3.433333333	Ovary	Serous Cystadenocarcinoma		14
BRCA1	Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)	TCGA-36-2542-01	Ovarian Epithelial Tumor	Serous Ovarian Cancer	N1268Tfs*3	OncoKB: Likely Oncogenic, level_1, resistance NA;CIViC: NA;CancerHotspot: no;3DHotspot: no			MutationAssessor: NA;SIFT: NA;Polyphen-2: NA;AlphaMissense: NA	Frame_Shift_Del	DEL	ShallowDel	.	.	.	17	41243733	41243745	TTACTGCAGTCAT	-	17:g.41243733_41243745del	ENST00000357654.3:c.3803_3815del	0.48		51	56		265	73	10/23					59			8		OV	657	-21902	0	21.59976329	0:DiseaseFree	21.59976329	0:ALIVE OR DEAD TUMOR FREE	Not Hispanic Or Latino	8/18/10	0.4333	EAS	G3	No	C56.9	8441/3	C56.9	No	Yes	0.2648	0.53		SOC	21.59976329	0:LIVING	7aadc24b-3de2-478f-b9e5-aca44424f514				Tumor Free	21.59976329	0:CENSORED			Asian	No		1	Primary	Female	Matched		209			BC Cancer Agency	36	2.5	Ovary	Serous Cystadenocarcinoma		
BRCA1	Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)	TCGA-36-2544-01	Ovarian Epithelial Tumor	Serous Ovarian Cancer	C328*	OncoKB: Likely Oncogenic, level_1, resistance NA;CIViC: NA;CancerHotspot: no;3DHotspot: no			MutationAssessor: NA;SIFT: NA;Polyphen-2: NA;AlphaMissense: NA	Frame_Shift_Del	DEL	ShallowDel	.	.	.	17	41246566	41246567	AT	-	17:g.41246566_41246567del	ENST00000357654.3:c.981_982del	0.61		99	62		156	64	10/23		Pathogenic	rs80357772	0.000058	58			3		OV	638	-21384	0			20.9751126	0:ALIVE OR DEAD TUMOR FREE		8/18/10	0.3392	EUR	G3	No	C56.9	8441/3	C56.9	No	Yes	0.296	1.76		SOC	20.9751126	0:LIVING	da56dfbe-35ae-4bd7-9a11-d9bbb02b1833				With Tumor	10.68481441	1:PROGRESSION				No		1	Primary	Female	Matched		363			BC Cancer Agency	36	2.133333333	Ovary	Serous Cystadenocarcinoma		
BRCA1	Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)	TCGA-61-1914-01	Ovarian Epithelial Tumor	Serous Ovarian Cancer	L474*	OncoKB: Likely Oncogenic, level_1, resistance NA;CIViC: NA;CancerHotspot: no;3DHotspot: no			MutationAssessor: NA;SIFT: NA;Polyphen-2: NA;AlphaMissense: NA	Nonsense_Mutation	SNP	Gain	.	.	.	17	41246127	41246127	A	C	17:g.41246127A>C	ENST00000357654.3:c.1421T>G	0.73		159	58		228	114	10/23		Pathogenic	rs80357490		65			9	23	OV	1722	-23850	0	55.03501332	1:Recurred/Progressed	56.61307821	0:ALIVE OR DEAD TUMOR FREE		10/1/09	0.4098	EUR	G3	No	C56.9	8441/3	C56.9	Yes	Yes	0.2599	0.61		SOC	56.61307821	0:LIVING	8e1b8811-1eb2-4337-852c-c19eaa0ee418				With Tumor	55.03501332	1:PROGRESSION				No	8	1	Primary	Female	Matched	OV	134			University of Pittsburgh	61	3.766666667	Ovary	Serous Cystadenocarcinoma		30
